Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Vicarious Surgical ( (RBOT) ) just unveiled an update.
On February 12, 2025, Vicarious Surgical announced the planned retirement of its Chief Operating Officer, John Mazzola, effective April 1, 2025. Mazzola, who has nearly 40 years of experience in healthcare manufacturing and quality control, has been pivotal in advancing the company’s manufacturing processes and supply chain resilience, positioning Vicarious Surgical for upcoming clinical use cases and trials. His responsibilities will transition to Randy Clark, the company’s President.
More about Vicarious Surgical
Vicarious Surgical, founded in 2014 and headquartered in Waltham, Massachusetts, is a next-generation robotics company focused on transforming robotic surgery. The company aims to enhance surgical efficiency, improve patient outcomes, and reduce healthcare costs through its proprietary human-like surgical robots. Supported by notable investors like Bill Gates and Vinod Khosla, Vicarious Surgical is led by a team of experienced technologists and medical professionals.
YTD Price Performance: 8.38%
Average Trading Volume: 48,417
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $88.62M
See more insights into RBOT stock on TipRanks’ Stock Analysis page.
